Researching a Novel NPC-related Candidate Suppressor Gene BRD7 by Two-dimensional Gel Electrophoresis and MALDI-TOF-MS

Acta Biochimica et Biophysica Sinica

Volumn 35, Issue 9, 2003, Pages 816-822

  Peng, Cong ^a   Liang, Song Ping ^b   Tan, Chen ^a   Lv, Hong Bin ^a   Huang, He ^a   Zhou, Min ^a   Wang, Rong ^a   Li, Xiao Lin ^a   Li, Gui Yuan ^a  

^a The First People s Hospital of Changde City)   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

BRD7 gene; Gene transfection; MAIDL TOF MS; Nasopharyngeal carcinoma; Two dimensional gel electrophoresis (2 DE)

Indexed keywords

ARGININOSUCCINATE LYASE; COMPLEMENTARY DNA; CYCLINE; LIPOSOME; METALLOPROTEINASE INHIBITOR; PROTEASOME; PROTEIN; PROTEIN BRD7; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE; DOWN REGULATION; GENE FUNCTION; GENE ISOLATION; GENETIC TRANSFECTION; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPRESSOR GENE; TRANSCRIPTION REGULATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; TWO HYBRID SYSTEM;

CARRIER PROTEINS; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; NUCLEAR PROTEINS; PLASMIDS; PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION; UP-REGULATION;

EID: 0347594326     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Lung ML, Sham JS, Lam WP, Choy DT. Analysis of localized tumors provides further evidence for the direct association of Epstein-Barr virus with nasopharyngeal carcinoma. Cancer, 1993, 71: 1190-1192
2. Choi PH, Suen MW, Huang DP, Lo KW, Lee JC. Nasopharyngeal carcinoma: Genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients. Cancer, 1993, 72(10): 2873-2878
3. Lo K, Huang PW, Lee CK. Genetic changes in nasopharyngeal carcinoma. Chin Med J (Engl), 1997, 110 (7): 548-549
4. Yu Y, Zhu SG, Zhang BC, Zhou M, Li XL, Li GY. Coding-region single nucleotide polymorphisms in BRD7gene and nasopharyngeal carcinoma susceptibility. Prog Biochem Biophys, 2000, 28 (4): 568-572
5. Yu Y, Zhu SG, Zhang BC, Zhou M, Li XL, Li GY. Screening of BRD7 interacting proteins by yeast two-hybrid system. Sci China Seri, 2002, 45 (5): 546-552
6. Tan C, Li J, Xie Y, Xiang Q, Wang JR, Liang SP, Li GY. Preliminary function study of NAG7 using two-dimensional eletrophoresis and mass spectrometry. Acta Biochim Biophys Sin, 2001, 33 (4): 373-378
7. Tan C, Li J, Xie Y, Xiang Q, Wang JR, Liang SP, Li GY. Identification and significance of down-regulated proteins in HNE1 cells transfected with NAG7. Chinese Journal of Biochemistry and Molecular Biology, 2001, 17 (6): 687-692
8. Tan C, Li J, Wang J, Xiang Q, Zhang X, Dong L, Shen S, Liang S et al. Proteomic analysis of differential protein expression in human nasopharyngeal carcinoma cells induced by NAG7 transfection. Proteomics, 2002, 2(3): 306-312
9. Li J, Tan C, Xiang Q, Zhang XM, Ma J, Li WF, Li GY et al. Search for differentially expressed proteins involved in the treatment of human nasopharyngeal carcinoma cells with NGX6 using two-dimensional electrophoresis and mass spectrometry. Prog Biochem Biophys, 2001, 28 (4): 573-578
10. Li J, Tan C, Xiang Q, Zhang XM, Ma J, Li WF, Li GY et al. Preliminary function study of a putative tumor suppressor gene in human nasopharyngeal carcinoma cells using two-dimensional electrophoresis and mass spectrometry. Chinese Journal of Cancer, 2001, 20 (7): 692-695
11. Ausubel FM et al. Short Protocols in Molecular Biology, 3rd ed. John Wiley&Son, Inc, 1995
12. Bergman AC, Benjamin T, AIaiya A, Waltham M, Sakaguchi K, Franzen B, Linder S et al. Identiffication of gel-separated tumor marker proteins by mass spectrometry. Electrophoresis, 2000, 21 (3): 679-686
13. Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Pegylated arginine deiminase (ADI-SS PEG20, 000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res, 2002, 62 (19): 5443-5450
14. Gopalakrishna R, Gundimeda U. Antioxidant regulation of protein kinase C in cancer prevention. J Nutr, 2002, 132 (12): 3819S-3823S
15. Hajitou A, Sounni NE, Devy L, Grignet-Debrus C, Lewalle JM, Li H, Deroanne CF et al. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: Effect on in vivo mammary tumor growth and angiogenesis. Cancer Res, 2001, 61 (8): 3450-3457
16. Hoegy SE, Oh HR, Corcoran ML, Stetter-Stevenson WG. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J Biol Chem, 2001, 276 (5): 3203-3214
17. DeClerck YA, Imren S, Montgomery AM, Mueller BM, Reisfeld RA, Laug WE. Proteases and protease inhibitors in tumor progression. Adv Exp Med Biol, 1997, 425: 89-97
18. Sijts A, Sun Y, Janek K, Kral S, Paschen A, Schadendorf D, Kloetzel PM. The role of the proteasome activator PA28 in MHC class I antigen processing. Mol Immunol, 2002, 39 (3-4):165-169
19. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, Schild H, Rammensee HG et al. A role for the proteasome regulator PA28 alpha in antigen presentation. Nature, 1996, 381 (6578): 166-168
20. Johnsen A, France J, Sy MS, Harding CV. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines. Cancer Res, 1998, 58 (16): 3660-3667
21. Fujita J, Ohtsuki Y, Bandoh S, Ueda Y, Kubo A, Tojo Y, Yamaji Y et al. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines. Lung Cancer, 2003, 39 (1): 31-36
22. Wieczorek TJ, Pinkus JL, Glickman JN, Pinkus GS. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Am J Clin Pathol, 2002, 118 (6): 911-921
23. Ordonez NG. Utilization of thyroid transcription factor-1 immunostaining in the diagnosis of lung tumors. Methods Mol Med, 2003, 75: 355-368
24. 2+ microdomains to mitochondria. J Cell Biol, 2002, 159 (4): 613-624
25. Bylund J, Bylund M, Oliw EH. cDNA cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun, 2001, 280 (3): 892-897
26. Hashizume T, Imaoka S, Hiroi T, Terauchi Y, Fuji T, Miyazaki H, Kamataki T et al. cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine. Biochem Biophys Res Commun, 2001, 280(4): 1135-1141
27. Ishii J, Adachi H, Aoki J, Koizumi H, Tomita S, Suzuki T, Tsujimoto M et al. SREC-II, a new member of the scavenger receptor type F family, trans-interacts with SREC-I through its extracellular domain. J Biol Chem, 2002, 277 (42): 39696-39702
28. Makela TP, Tassan JP, Nigg EA, Frutiger S, Hughes GJ, Weinberg RA. A cyclin associated with the CDK-activating kinase MO15. Nature, 1994, 371 (6494): 254-257
29. Matsuoka M, Kato JY, Fisher RP, Morgan DO, Sherr CJ. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol Cell Biol, 1994, 14 (11): 7265-7275
30. de Vos J, Thykjaer T, Tarte K, Ensslen M, Raynaud P, Requirand G, Pellet F et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene, 2002, 21 (44): 6848-6857
31. Underwood LJ, Tanimoto H, Wang Y, Shigemasa K, Parmley TH, O' Brien TJ. Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res, 1999, 59(17): 4435-4439
32. Magklara A, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Danese S et al. The human KLK8 (neuropsin/ovasin) gene: Identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res, 2001, 7 (4): 806-811